AAV itself is a small, non-enveloped virus that belongs to the Parvoviridae family. It is considered non-pathogenic to humans, making it ideal for therapeutic applications. AAV serotype 6 is one of several serotypes with unique tissue tropism and cellular entry mechanisms that allow for targeted gene delivery. Specifically, AAV6 is known for its efficient transduction in a variety of cell types, including muscle, liver, and lung tissue, making it particularly useful for studies involving these organs.
LacZ adeno-associated virus (AAV) serotype 6 is a viral vector commonly used in gene therapy and biomedical research. The LacZ gene is often used as a reporter gene in various studies because it encodes the enzyme β-galactosidase. This enzyme plays a key role in metabolic processes by breaking down lactose into glucose and galactose. The enzyme is easily detected and quantified, allowing researchers to track gene expression and cellular processes. Researchers use LacZ AAV6 in a variety of experimental settings, such as studying gene function or evaluating the effectiveness of gene therapy approaches.
Cardiomyocytes (CMs) generated from human induced pluripotent stem cells (hiPSCs) are an evolving platform for understanding molecular disease mechanisms and evaluating cardiovascular drugs. A major limitation of this system is that they represent a heterogeneous mixture of ventricular-, atrial-, and nodal-like CMs. By expressing voltage-sensitive fluorescent proteins under the control of lineage-specific promoters, researchers have developed a convenient system that allows high-throughput subtype-specific optical action potential (AP) imaging in these cells. This not only allows for quantification of electrical phenotypes in patient-specific CMs, but also allows for the study of subtype-specific drug effects, which may aid drug development and safety pharmacology in the cardiovascular field.
Here, wild-type (wt) KCNQ1 ion channel subunits were overexpressed in hiPSC-derived LQT1R190Q CMs via adeno-associated virus (AAV6)-mediated gene transfer (Figure 1A). The mutated KCNQ1 gene encodes a transport-deficient ion channel subunit that interacts with the wild-type subunit and interferes with its integration into the plasma membrane, resulting in a dominant-negative effect, which might be overcome by overexpression of wild-type subunits. AP was optically recorded seven days after LQT1R190Q CM infection with MLC2v-VSFP lentivirus, followed by AAV6 virus encoding wt KCNQ1 fused to a hemagglutinin (HA) epitope tag (wt KCNQ1-HA AAV6) or a control virus encoding LacZ (LacZ-AAV6) infected cells. Three days later (day 10), AP was recorded again in the same cells, and post hoc staining for the HA epitope and β-gal transgene was performed to confirm viral transduction of the study cells (Figure 1A). Indeed, wt KCNQ1 overexpression significantly shortened the AP of LQT1R190Q CM (Figure 1B and D ), reaching APD values similar to those measured in LQT1corr cells. In contrast, no changes in APD were detected in CM infected with LacZ-AAV6 (Figure 1C and D). Therefore, sequential AP imaging in the same cells using the MLC2v-VSFP sensor can detect successful LQT1 phenotype rescue in patient-derived hiPSC-CMs.
Figure 1. Measurements of dynamic changes in action potential duration in single cells over time. (Chen Z, et al., 2017)
Customer Reviews
Invaluable tool
Our laboratory requires precise targeting for our genetic experiments, and the AAV6 serotype has been perfect for our needs.
Write a Review